BT
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Organization · DC
Hires government relations
Who they hire
What they lobby on
-H.R 8698, SCREEN for Type 1 Diabetes Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 4504, SCREEN Act (A bill to amend the Public Health Service Act to provide for a public awareness campaign with respect to screening for type 1 diabetes, and for other purposes). -S. 1269, INSULIN Act of 2023. -S. 1855, Special Diabetes Program Reauthorization Act of 2023. -H.R. 2550, Special Diabetes Program Reauthorization Act of 2023. -H.R 1499, Affordable Insulin Now Act. -S. 954, Affordable Insulin Now Act of 2023. -H.R. 5378, Lower Costs, More Transparency Act. -H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023. -Issues related to cell and gene therapies.
H.R. 9029, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024. H.R. 4366 - Consolidated Appropriations Act of 2024. H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act. Issues pertaining to NIH appropriations for FY25.
Legislative outreach and monitoring related to insulin affordability. S. 1269 - INSULIN Act of 2023. S. 1855 - Special Diabetes Program Reauthorization Act of 2023.